Krka, d. d. (LJSE: KRKG)
Health Care · Pharmaceuticals · SI
€257.50
-0.19% today · +29.4% 1Y
Krka, d. d. (LJSE: KRKG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.73B.
Over the last twelve months the share price has gained 29.4%, trading between 174.00 and 270.00.
Tweenvest scores Krka, d. d. across four factors: quality 87/100, value 23/100, growth 60/100, dividend 100/100. Its strongest factor is dividend.
KRKG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.73B
- Revenue (TTM)
- $2.41B
- P/E
- 18.73
- EPS
- 13.75
- Dividend yield
- 3.53%
- Beta (5Y)
- 0.44
- 52-week high
- €270.00
- 52-week low
- €174.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.28M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sichuan Kelun Pharmaceutical Co., Ltd.SZSE: 002422 | $9.69B | CN¥40.85 | +5.12% |
| Lupin LimitedBSE: 500257 | $9.64B | Rs2,029.00 | -2.92% |
| Axsome Therapeutics, Inc.NasdaqGM: AXSM | $9.06B | $170.08 | -1.67% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd.SHSE: 600196 | $8.79B | CN¥24.02 | +5.17% |
| Financière de Tubize SAENXTBR: TUB | $8.51B | €170.80 | +0.65% |
| Eisai Co., Ltd.TSE: 4523 | $8.27B | ¥4,640.00 | -0.77% |
| Shanghai Allist Pharmaceuticals Co., Ltd.SHSE: 688578 | $7.49B | CN¥111.58 | +7.06% |
| Kyowa Kirin Co., Ltd.TSE: 4151 | $7.31B | ¥2,209.00 | -0.41% |
Figures last refreshed Oct 4, 2026.